I agree that this site is using cookies. You can find further informations here.
X
YALÇIN, Arzu Didem
246  results:
Search for persons X
?
1

Omalizumab and cancer risk: Current evidence in allergic as..:

Bagnasco, Diego ; Canevari, Rikki Frank ; Del Giacco, Stefano...
World Allergy Organization Journal.  15 (2022)  12 - p. 100721 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Country-based report: the safety of omalizumab treatment in..:

GEMİCİOĞLU, Bilun ; YALÇIN, Arzu Didem ; HAVLUCU, Yavuz...
TURKISH JOURNAL OF MEDICAL SCIENCES.  51 (2021)  5 - p. 2516-2523 , 2021
Link: https://doi.org/10.3906/..
 
?
3

Human(ized) monoclonal antibodies in atopic patients – stat..:

Yalcin, Arzu Didem ; Onbasi, Kevser ; Uzun, Rusen..
Central European Journal of Immunology.  45 (2020)  2 - p. 195-201 , 2020
Link: https://doi.org/10.5114/..
 
?
4

The IL4-VNTR P1 Allele, IL4-VNTR P2P2 Genotype, and IL4-VNT..:

Gunal, Ozgur ; Yigit, Serbulent ; Yalcın, Arzu Didem...
Japanese Journal of Infectious Diseases.  70 (2017)  1 - p. 61-64 , 2017
Link: https://doi.org/10.7883/..
 
?
5

Vitamin D serum levels in allergic rhinitis:

Kose, Sukran ; Senger, Süheyla Serin ; Yalcin, Arzu Didem..
World Allergy Organization Journal.  8 (2015)  - p. A67 , 2015
Link: https://doi.org/10.1186/..
 
?
6

Circulating apo 2L levels decreased in hepatitis C with the..:

Yalcin, Ata Nevzat ; Yalcin, Arzu Didem ; Celik, Betul...
World Allergy Organization Journal.  8 (2015)  - p. A8 , 2015
Link: https://doi.org/10.1186/..
 
?
7

Advances in Anti-IgE Therapy:

Yalcin, Arzu Didem
BioMed Research International.  2015 (2015)  - p. 1-11 , 2015
Link: https://doi.org/10.1155/..
 
?
8

Circulating soluble apo 2L, soluble OX-2: a possible screen..:

Yalcin, Arzu Didem ; Celik, Betul ; Kumru, Selahattin.
World Allergy Organization Journal.  8 (2015)  - p. A12 , 2015
Link: https://doi.org/10.1186/..
 
?
9

Omalizumab in symptomatic therapy of laryngeal oedema and u..:

Yalcin, Arzu Didem ; Suer, Kaya
World Allergy Organization Journal.  8 (2015)  - p. A246 , 2015
Link: https://doi.org/10.1186/..
 
?
10

Evaluation of sOX-2 levels in type2 diabetic foot and nephr..:

Yalcin, Arzu Didem ; Arik, Hasan Onur ; Celik, Betul...
World Allergy Organization Journal.  8 (2015)  - p. A9 , 2015
Link: https://doi.org/10.1186/..
 
?
11

1347Evaluation of Circulating sCD200 (OX-2), High Sensitive..:

Oztoprak, Nefise ; Yalcin, Arzu Didem ; Genc, Gizem Esra..
Open Forum Infectious Diseases.  1 (2014)  suppl_1 - p. S352-S353 , 2014
Link: https://doi.org/10.1093/..
 
?
12

An Overview of the Effects of anti-IgE Therapies:

Yalcin, Arzu Didem
Medical Science Monitor.  20 (2014)  - p. 1691-1699 , 2014
Link: https://doi.org/10.12659..
 
?
13

Health outcomes, education, healthcare delivery and quality..:

Yalcin, Arzu Didem ; Bisgin, Atil
World Allergy Organization Journal.  6 (2013)  - p. P212 , 2013
Link: https://doi.org/10.1186/..
 
?
14

Environmental and occupational respiratory diseases – 1062...:

Yalcin, Arzu Didem ; Basaran, Saime ; Bisgin, Atil.
World Allergy Organization Journal.  6 (2013)  - p. P60 , 2013
Link: https://doi.org/10.1186/..
 
?
15

Basic and clinical immunology – 3031. The correlation betwe..:

Yalcin, Arzu Didem ; Bisgin, Atil ; Kargi, Aysegul...
World Allergy Organization Journal.  6 (2013)  - p. P206 , 2013
Link: https://doi.org/10.1186/..
 
1-15